Imaging agent developer ImaginAb appointed Ian Wilson as its new chief operating officer (COO).
Wilson has more than 25 years of leadership in commercial development of in vivo medical diagnostics and imaging medical devices. From 2004 to 2017, Wilson served as CEO and chief technology officer (CTO) of Edinburgh Molecular Imaging, where he led the development of optical imaging agents to improve cancer detection, surgery, and lung disease.
Previously, he held CTO and COO roles at Xstrahl where he was responsible for the oversight of radiotherapy commercial operations and manufacturing, including new product development, according to ImaginAb. Wilson also worked previously at GE Healthcare.
